NCT06456489View on ClinicalTrials.gov

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Active Rheumatoid Arthritis
Interventions
DRUG

Solumedrol

125 mg methylprednisolone intravenous pulse on 2 consecutive days

Trial Locations (1)

Unknown

RECRUITING

Al-Azhar Univrsity, Cairo

All Listed Sponsors
lead

Sohag University

OTHER